AzTrials
AzTrials

Emotional DisturbanceNCT06662357

Family Connections

A study testing Behavioral Treatment in people with Emotional Disturbance and Behavior Disorders in Children, run by Cambridge Health Alliance at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The Family Connections study, is intended to disrupt disparities in mental health treatment access for children at-risk for childhood trauma (ACEs) and/or serious emotional disturbance (SED). "Family Connections" will use mobile clinical and family support teams to improve mental health outcomes. Read more about this study

Who is it for?
Ages 3 to 18 years
What is being tested?
Behavioral Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteUnited States
Study dates
30 Jan 2025to 29 Sep 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • 3 through 18 years (17½ years maximum at time of enrollment)
  • Referred by Primary Care Physician's (PCP) from one of the three Cambridge Health Alliance (CHA) primary care intervention sites to the Family Connections team for an integrated child mental health and/or substance use disorder clinical assessment.
  • Positive screen on CHA's standard pediatric mental health and substance use screening instruments, and/or parental concern about possible mental health/substance use needs, and/or PCP concern about possible mental health/substance use needs
  • Enrolled in MassHealth

Who cannot join

  • Subjects over 17.5 years (SAMHSA data collection required at 6 and 12 months after enrollment which must occur before age 18 years.)
  • Youth who are not enrolled in MassHealth
  • CHA patients with PCP located at CHA primary care site other than the identified intervention sites

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Katherine E Grimes, MD, MPH contact

617-806-8718

katherine_grimes@hms.harvard.edu

Program Administrator, MPH contact

857-260-2867

amaity@challiance.org

United States1 site, 1 recruiting
  • Cambridge Health Alliance

    Cambridge, Massachusetts, 02139

    Katherine Grimes, Md, MPH, 857-523-8398

    Recruiting

Other trials in United States

About this study

Official title: Family Connections: A Community-Based Approach to Expanding Mental Health Access and Engagement for SED Youth

The Family Connections study, is intended to disrupt disparities in mental health treatment access for children at-risk for childhood trauma (ACEs) and/or serious emotional disturbance (SED). "Family Connections" will use mobile clinical and family support teams to improve mental health outcomes. This clinical innovation, nested in an integrated system-of-care will be piloted for children, ages 3-18 yrs., with SED who receive primary care through Cambridge Health Alliance.

Being tested
Behavioral Treatment
Medical subject headings
Affective Symptoms, Child Behavior Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral TreatmentBehavioural

    "Family Connections" Care Planning Team: Clinical expertise will be combined with peer-to-peer parent/guardian support for trauma-informed care delivery to both parent and child. All aspects of the care continuum will be provided in a culturally and linguistically competent manner, with child and family-driven care planning.

Study groups in NCT06662357
Study groupRoleWhat they receive
Active Comparator: Family Connections InterventionActive comparatorNot described
Receives: Behavioral: Behavioral Treatment
Treatment as UsualNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Child and Adolescent Functional Assessment Scale (CAFAS) Score

    Comparative analysis of baseline and follow-up clinical functioning scores

    CAFAS Scoring:

    Levels of Dysfunction None or minimal 0-10 Mild 20-30 Moderate 40-60 Marked 70-80 Severe >90

    Measured: Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months

  2. Changes in Children's Global Assessment Scale (CGAS) Score

    Comparative analysis of baseline and follow-up clinical functioning scores

    CGAS Scale:

    100-91 Superior functioning 90-81 Good functioning 80-71 No more than a slight impairment in functioning 70-61 Some difficulty in a single area, but generally functioning pretty well 60-51 Variable functioning with sporadic difficulties 50-41 Moderate degree of interference in functioning 40-31 Major impairment to functioning in several areas 30-21 Unable to function in almost all areas 20-11 Needs considerable supervision 10-1 Needs constant supervision

    Measured: Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months

  3. Family perceptions of care using the Family Professional Partnership Scale (FPPS).

    Analysis of baseline and follow-up family perceptions of care (18 Questions):

    1. - Very Dissatisfied
    2. - Dissatisfied
    3. - Neither
    4. - Satisfied
    5. - Very Satisfied

    Measured: Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months

  4. Access to child mental health and substance abuse (MH/SA) care

    Comparative analysis of access to care trends

    Measured: 0-6 months

  5. Engagement in child mental health and substance abuse (MH/SA) treatment

    Comparative analysis of service use trends

    Measured: 6-12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2024
  2. Study start30 Jan 2025
  3. Primary completionJul 2028 (estimated)
  4. Study completion29 Sep 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The Family Connections Model consists of the delivery of intensively integrated clinical care within pediatrics, combined with community-based parent support from family support specialists. Innovations include child mental health specialists joining the pediatrics team for "huddles", psychiatry notes shared with pediatricians via the Electronic Medical Records and active inclusion of pediatricians in pre-evaluation discussions with the Family Connections Team and post-evaluation recommendations for the families. In addition, the Safety-Net model includes active communication with school personnel, child welfare, and community-based resources, when needed.
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06662357
Sponsor's protocol ID
H79SM089682
Other IDs
H79SM089682
Status last verified
Sep 2026
First submitted
25 Oct 2024
Last updated
22 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral Treatment in people with Emotional Disturbance and Behavior Disorders in Children, run by Cambridge Health Alliance at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Katherine E Grimes, MD, MPH (617-806-8718, katherine_grimes@hms.harvard.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Child and Adolescent Functional Assessment Scale (CAFAS) Score (time frame: Baseline collected at enrollment, follow-up assessments collected at 6 months and 12 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in